📰 D News
Page 1044 - D News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from D. Real-time updates on events, politics, business and more.
January 4, 2024
William Hawkins, MD, will join MUSC Hollings Cancer Center on January 1, 2024, as deputy director, where he will focus on strengthening translational research, increasing clinical trials across South Carolina and assisting Craig Lockhart, MD, with making clinical operations more efficient.
January 4, 2024
The award-winning animated short uses live-action and hand-drawn animation to tackle the complex story of a Holocaust survivor who addresses a classroom full of students and one young schoolgirl’s reaction; streams on YouTube for 2-days only – beginning January 4.
January 4, 2024
"Meet the new chair of UVA School of Medicines ophthalmology department, Dr. Albert Jun, a pioneer in corneal transplants and former chief at Johns Hopkins Uni
January 4, 2024
PRINCE GEORGE’S COUNTY, Md. (DC News Now) — Police released the name of a man who was killed after a vehicle hit him New Year’s Day night in Cheverly. The Prince George’s County Police Department (PGPD) said Tom Gregorio, 50, of Cheverly died in the roadway near Landover Road and Neighbor Lane. Officers went to […]
January 4, 2024
0.07 ACRE VACANT LOT in FAIRFIELD, AL! Item ID: Kiddu02Owner: Harriet Kiddu IMPORTANT LEGAL INFO: IF YOU HAVE LESS THAN 5 FEEDBACK, PLEASE CONTACT ME AT 480-396-0716 PRIOR TO BIDDING. IF YOU DO NOT CO | RealGeni.com
January 4, 2024
The safety and efficacy data observed with the administration of 5 or more cycles of induction platinum/etoposide and concurrent durvalumab in patients with extensive-stage small cell lung cancer enrolled in the phase 3b LUMINANCE study aligned with outcomes reported in the phase 3 CASPIAN trial.
January 4, 2024
Pooja Advani, MBBS, MD, details key advancements and the significance of pivotal trials that were presented by her colleagues at a recent OncLive® State of the Science Summit™ on breast cancer, which she chaired.
January 4, 2024
Dr Gradishar discusses the FDA approval of capivasertib plus fulvestrant for patients with advanced HR-positive, HER2-negative breast cancer harboring PIK3CA, AKT1, or PTEN alterations.
January 3, 2024
Lori A. Leslie, MD, discusses the efficacy and safety of second-line axicabtagene ciloleucel in elderly patients with high-risk, relapsed/refractory large B-cell lymphoma.
January 3, 2024
MULLAN, Idaho - No snow means no winter, and no snow means no free ski school, at least for now.